Morgan Sindall has been selected as the preferred bidder for a £26 million project to build a centre of excellence for neuroscience research at King’s College London.
The firm has been appointed to deliver a five-storey facility that will house the Maurice Wohl Clinical Neuroscience Institute at the college’s Denmark Hill West Campus. The centre will see King’s College London and King’s College Hospital work together to create one of Europe’s leading facilities for neuroscience research.
The scheme, which was designed by Devereux Architects with Allies & Morrison, will provide accommodation for more than 220 researchers, office facilities and a 100-seat flexible seminar space. It will also create a new public court between the James Black Centre, the Maurice Wohl Clinical Neuroscience Institute and the Weston Education Centre.
The iconic building, which will incorporate perforated copper cladding and automated Brise Soleil, is designed to achieve a BREEAM rating of ‘Excellent.’ Its sustainable features will include ground source heating, combined heat and power (CHP) and natural ventilation with active chilled beams.
The 8,400m² concrete frame building will be constructed on piled foundations with glazed, concrete faced and metal clad elevations.
Peter Jacobs, the recently appointed managing director for Morgan Sindall London, says: “It was a tough tender process and we’re delighted to be working with one of the UK’s leading medical research institutions. It will also make a significant contribution to our growth plans for the London region and highlights our expertise and capability in delivering technically-challenging major projects.”
The centre will bring a bold new approach to a range of neurological and psychiatric conditions which affect millions of people and for which there are currently few effective treatments. These include strokes, dementia, Parkinson’s Disease, motor neurone disease, brain tumours, epilepsy, schizophrenia and depression.
The scheme is being funded by the Higher Education Funding Council England, The Science Research Investment Fund and private donations from the Maurice Wohl Foundation, the Wolfson Foundation, the King’s Medical Research Trust, and South London and Maudsley NHS Foundation Trust. It is due to be completed in spring 2013.
Pictured: An artist's impression of the Maurice Wohl Clinical Neuroscience Institute